News Release

<< Back

  View printer-friendly version

Teleflex Incorporated Announces Benson Smith to Retire as Chief Executive Officer at End of 2017; Liam Kelly to Succeed Smith as Chief Executive Officer

WAYNE, Pa.--(BUSINESS WIRE)--Feb. 23, 2017-- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, announced today that Benson Smith will retire from his position as Chief Executive Officer, effective on December 31, 2017. Mr. Smith, a Teleflex Board member since 2005, will continue to serve as Teleflex’s Chairman of the Board. He has been nominated by Teleflex’s Board of Directors to serve for another three year term if elected by Teleflex’s stockholders at the 2017 annual meeting to be held in May, 2017.

“I want to thank the Board of Directors, along with all of our employees and shareholders, for the opportunity to serve on the executive management team at Teleflex,” said Mr. Smith. “When I began my tenure as CEO in 2011, Teleflex was completing its transition from a diversified industrial company, and I’m proud that in less than a decade we have been able to successfully grow into our current position as a leading global provider of medical devices. I have tremendous confidence in my colleague, Liam Kelly, and the talented executives that we have been able to attract and develop at Teleflex, and I look forward to Teleflex’s continued success under Liam’s leadership and strategic guidance.”

Liam Kelly, who currently serves as Teleflex’s President and Chief Operating Officer, has been named by the Teleflex Board of Directors to succeed Mr. Smith as Chief Executive Officer following Mr. Smith’s retirement.

“I’m grateful to Benson for his years of leadership as CEO, under which Teleflex has continuously expanded and improved its capabilities as a diversified, global provider of medical technologies, and I’m excited by the prospect of leading Teleflex through the Company’s next stage of growth and development,” said Mr. Kelly.


Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation - a relentless pursuit of identifying unmet clinical needs - to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch® and Weck® - trusted brands united by a common sense of purpose.


This press release contains forward-looking statements, including, but not limited to, statements related to the occurrence of, and arrangements related to, Mr. Smith’s retirement as, and Mr. Kelly’s designation as, Teleflex’s Chief Executive Officer.. Actual results could differ materially from those in the forward-looking statements due to, among other things, the stockholder vote at Teleflex’s 2017 annual meeting and other factors described or incorporated in our filings with the Securities and Exchange Commission (“SEC”), including our Annual Report on Form 10-K for the year ended December 31, 2015.

Source: Teleflex Incorporated

Teleflex Incorporated
Jake Elguicze
Treasurer and Vice President of Investor Relations